EcoDrugPlus

Integrin Subunit Beta 6

Ensembl ID : ENSPCTG00005009996
Gene Symbol: ITGB6
3 Cross references
206 Possible Orthologues:

Integrin Subunit Beta 7

Ensembl ID : ENSPCTG00005010788
Gene Symbol: ITGB7
3 Cross references
160 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSPCTG00005016513
Gene Symbol: IRAK4
3 Cross references
202 Possible Orthologues:

Interleukin 6

Ensembl ID : ENSPCTG00005003017
Gene Symbol: IL6
1 Cross references
162 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSPCTG00005005473
Gene Symbol: KDR
3 Cross references
197 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSPCTG00005006181
Gene Symbol: LTA4H
3 Cross references
207 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSPCTG00005015101
Gene Symbol: LOXL2
3 Cross references
287 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSPCTG00005015389
Gene Symbol: MIF
1 Cross references
218 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSPCTG00005008853
Gene Symbol: MST1R
1 Cross references
266 Possible Orthologues:

Maltase-Glucoamylase

Ensembl ID : ENSPCTG00005001373
Gene Symbol: MGAM
1 Cross references
312 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSPCTG00005007864
Gene Symbol: MMP1
1 Cross references
352 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSPCTG00005007790
Gene Symbol: MMP13
3 Cross references
200 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).